Skip to main content
. Author manuscript; available in PMC: 2021 Jan 20.
Published in final edited form as: Biochem Biophys Res Commun. 2020 Dec 10;534:67–72. doi: 10.1016/j.bbrc.2020.11.117

Figure 1.

Figure 1.

Top left: Markush structures of thalidomide analogs based on scaffolds A and B. Top right: Dose response curves for Thalidomide, Gu3041, Gu3408 and 3364 as assayed by competitive MST experiments to human TBD. Bottom: Affinities to hTBD and IC50 values in the tube formation and RAR assay.